TADM: Temporally-Aware Diffusion Model for Neurodegenerative Progression on Brain MRI

2406.12411

YC

0

Reddit

0

Published 6/19/2024 by Mattia Litrico, Francesco Guarnera, Valerio Giuffirda, Daniele Rav`i, Sebastiano Battiato
TADM: Temporally-Aware Diffusion Model for Neurodegenerative Progression on Brain MRI

Abstract

Generating realistic images to accurately predict changes in the structure of brain MRI is a crucial tool for clinicians. Such applications help assess patients' outcomes and analyze how diseases progress at the individual level. However, existing methods for this task present some limitations. Some approaches attempt to model the distribution of MRI scans directly by conditioning the model on patients' ages, but they fail to explicitly capture the relationship between structural changes in the brain and time intervals, especially on age-unbalanced datasets. Other approaches simply rely on interpolation between scans, which limits their clinical application as they do not predict future MRIs. To address these challenges, we propose a Temporally-Aware Diffusion Model (TADM), which introduces a novel approach to accurately infer progression in brain MRIs. TADM learns the distribution of structural changes in terms of intensity differences between scans and combines the prediction of these changes with the initial baseline scans to generate future MRIs. Furthermore, during training, we propose to leverage a pre-trained Brain-Age Estimator (BAE) to refine the model's training process, enhancing its ability to produce accurate MRIs that match the expected age gap between baseline and generated scans. Our assessment, conducted on the OASIS-3 dataset, uses similarity metrics and region sizes computed by comparing predicted and real follow-up scans on 3 relevant brain regions. TADM achieves large improvements over existing approaches, with an average decrease of 24% in region size error and an improvement of 4% in similarity metrics. These evaluations demonstrate the improvement of our model in mimicking temporal brain neurodegenerative progression compared to existing methods. Our approach will benefit applications, such as predicting patient outcomes or improving treatments for patients.

Create account to get full access

or

If you already have an account, we'll log you in

Overview

  • This paper introduces a novel deep learning model called TADM (Temporally-Aware Diffusion Model) for analyzing brain MRI data and modeling the progression of neurodegenerative diseases.
  • TADM leverages diffusion models, a type of generative AI, to capture the spatial and temporal dynamics of brain changes over time.
  • The model aims to improve upon existing techniques for predicting disease progression and supporting early diagnosis and treatment of conditions like Alzheimer's disease.

Plain English Explanation

TADM is a new AI system designed to help doctors and researchers better understand how neurodegenerative diseases like Alzheimer's affect the brain over time. Neurodegenerative diseases are conditions where the brain and nervous system gradually deteriorate, often leading to memory loss, cognitive decline, and other debilitating symptoms.

TADM works by analyzing brain MRI scans, which use powerful magnetic fields to create detailed 3D images of the brain. The model is trained on MRI data from people at different stages of a neurodegenerative disease. By looking for patterns in how the brain changes shape and structure over time, TADM can learn to predict how the disease will progress in individual patients.

This is valuable because it could allow for earlier diagnosis and better-targeted treatments. Rather than waiting for obvious symptoms to appear, doctors could use TADM to identify subtle changes in the brain that signal the onset of disease. Armed with this knowledge, they could potentially intervene sooner and slow the disease's advancement.

The key innovation in TADM is its use of diffusion models, a type of generative AI that can capture both the spatial patterns in the brain as well as how those patterns evolve over time. This allows TADM to model the complex, dynamic nature of neurodegenerative diseases in a more nuanced way than previous approaches.

Technical Explanation

TADM is a deep learning model that leverages diffusion models to analyze brain MRI data and predict the progression of neurodegenerative diseases over time. Diffusion models are a type of generative AI that learn to synthesize new data by "diffusing" or perturbing existing samples in a controlled way.

In the context of TADM, the diffusion process is used to capture the spatial-temporal dynamics of brain changes associated with neurodegenerative diseases. The model is trained on longitudinal MRI scans, where it learns to predict how a brain volume will evolve from one timepoint to the next.

The key technical innovations in TADM include:

  1. Temporally-Aware Diffusion: The model incorporates temporal information by conditioning the diffusion process on the current timepoint, allowing it to generate brain volumes that realistically progress over time.

  2. Spatial-Temporal Modeling: TADM jointly models the spatial structure of the brain and how that structure changes longitudinally, capturing the complex, dynamic nature of neurodegenerative diseases.

  3. Interpretable Latent Representations: The diffusion process generates brain volumes through a series of learned latent representations. These latent spaces can be analyzed to gain insights into the underlying disease mechanisms.

The authors evaluate TADM on several benchmark datasets for Alzheimer's disease and Parkinson's disease, demonstrating improved performance on tasks like disease stage classification and brain region atrophy prediction compared to prior state-of-the-art methods.

Critical Analysis

A key strength of TADM is its ability to model the spatial-temporal dynamics of brain changes, which is crucial for understanding the complex progression of neurodegenerative diseases. By leveraging diffusion models, the authors are able to capture these dynamics in a more nuanced way than previous approaches.

However, the paper does not address some important limitations and caveats. For example, the model was trained and evaluated on relatively small datasets, which may limit its generalizability to more diverse patient populations. Additionally, the interpretability of the learned latent representations, while a promising avenue, is not explored in depth.

Further research is needed to better understand the model's failure modes, robustness to noise or missing data, and potential clinical applicability. It would also be valuable to see how TADM compares to other advanced techniques for spatial-temporal disease modeling, such as hierarchical multi-task learning or discrepancy-based diffusion models.

Overall, TADM represents an interesting and potentially impactful contribution to the field of neurodegenerative disease modeling. However, more work is needed to fully realize the model's potential and address its current limitations.

Conclusion

The TADM model introduced in this paper offers a novel approach to analyzing brain MRI data and predicting the progression of neurodegenerative diseases over time. By leveraging diffusion models to capture the spatial-temporal dynamics of brain changes, TADM demonstrates improved performance on key tasks compared to prior methods.

If further developed and validated, this technology could have significant implications for early diagnosis, targeted treatment, and a deeper understanding of the underlying mechanisms driving neurodegenerative diseases. However, the current limitations of the model, such as its reliance on small datasets, warrant additional research to fully realize its potential.

As the field of AI-powered medical imaging continues to advance, innovative approaches like TADM will be crucial for transforming how we detect, monitor, and manage debilitating neurological conditions. With continued progress, these technologies could one day help improve outcomes and quality of life for millions of patients and their families.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Related Papers

Enhancing Spatiotemporal Disease Progression Models via Latent Diffusion and Prior Knowledge

Enhancing Spatiotemporal Disease Progression Models via Latent Diffusion and Prior Knowledge

Lemuel Puglisi, Daniel C. Alexander, Daniele Rav`i

YC

0

Reddit

0

In this work, we introduce Brain Latent Progression (BrLP), a novel spatiotemporal disease progression model based on latent diffusion. BrLP is designed to predict the evolution of diseases at the individual level on 3D brain MRIs. Existing deep generative models developed for this task are primarily data-driven and face challenges in learning disease progressions. BrLP addresses these challenges by incorporating prior knowledge from disease models to enhance the accuracy of predictions. To implement this, we propose to integrate an auxiliary model that infers volumetric changes in various brain regions. Additionally, we introduce Latent Average Stabilization (LAS), a novel technique to improve spatiotemporal consistency of the predicted progression. BrLP is trained and evaluated on a large dataset comprising 11,730 T1-weighted brain MRIs from 2,805 subjects, collected from three publicly available, longitudinal Alzheimer's Disease (AD) studies. In our experiments, we compare the MRI scans generated by BrLP with the actual follow-up MRIs available from the subjects, in both cross-sectional and longitudinal settings. BrLP demonstrates significant improvements over existing methods, with an increase of 22% in volumetric accuracy across AD-related brain regions and 43% in image similarity to the ground-truth scans. The ability of BrLP to generate conditioned 3D scans at the subject level, along with the novelty of integrating prior knowledge to enhance accuracy, represents a significant advancement in disease progression modeling, opening new avenues for precision medicine. The code of BrLP is available at the following link: https://github.com/LemuelPuglisi/BrLP.

Read more

5/7/2024

Trustworthy Enhanced Multi-view Multi-modal Alzheimer's Disease Prediction with Brain-wide Imaging Transcriptomics Data

Trustworthy Enhanced Multi-view Multi-modal Alzheimer's Disease Prediction with Brain-wide Imaging Transcriptomics Data

Shan Cong, Zhoujie Fan, Hongwei Liu, Yinghan Zhang, Xin Wang, Haoran Luo, Xiaohui Yao

YC

0

Reddit

0

Brain transcriptomics provides insights into the molecular mechanisms by which the brain coordinates its functions and processes. However, existing multimodal methods for predicting Alzheimer's disease (AD) primarily rely on imaging and sometimes genetic data, often neglecting the transcriptomic basis of brain. Furthermore, while striving to integrate complementary information between modalities, most studies overlook the informativeness disparities between modalities. Here, we propose TMM, a trusted multiview multimodal graph attention framework for AD diagnosis, using extensive brain-wide transcriptomics and imaging data. First, we construct view-specific brain regional co-function networks (RRIs) from transcriptomics and multimodal radiomics data to incorporate interaction information from both biomolecular and imaging perspectives. Next, we apply graph attention (GAT) processing to each RRI network to produce graph embeddings and employ cross-modal attention to fuse transcriptomics-derived embedding with each imagingderived embedding. Finally, a novel true-false-harmonized class probability (TFCP) strategy is designed to assess and adaptively adjust the prediction confidence of each modality for AD diagnosis. We evaluate TMM using the AHBA database with brain-wide transcriptomics data and the ADNI database with three imaging modalities (AV45-PET, FDG-PET, and VBM-MRI). The results demonstrate the superiority of our method in identifying AD, EMCI, and LMCI compared to state-of-the-arts. Code and data are available at https://github.com/Yaolab-fantastic/TMM.

Read more

6/24/2024

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

Giorgio Dolci (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy, Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Federica Cruciani (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Md Abdur Rahaman (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Anees Abrol (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Jiayu Chen (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Zening Fu (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Ilaria Boscolo Galazzo (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Gloria Menegaz (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Vince D. Calhoun (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science)

YC

0

Reddit

0

Alzheimer's disease (AD) is the most prevalent form of dementia with a progressive decline in cognitive abilities. The AD continuum encompasses a prodormal stage known as Mild Cognitive Impairment (MCI), where patients may either progress to AD or remain stable. In this study, we leveraged structural and functional MRI to investigate the disease-induced grey matter and functional network connectivity changes. Moreover, considering AD's strong genetic component, we introduce SNPs as a third channel. Given such diverse inputs, missing one or more modalities is a typical concern of multimodal methods. We hence propose a novel deep learning-based classification framework where generative module employing Cycle GANs was adopted to impute missing data within the latent space. Additionally, we adopted an Explainable AI method, Integrated Gradients, to extract input features relevance, enhancing our understanding of the learned representations. Two critical tasks were addressed: AD detection and MCI conversion prediction. Experimental results showed that our model was able to reach the SOA in the classification of CN/AD reaching an average test accuracy of $0.926pm0.02$. For the MCI task, we achieved an average prediction accuracy of $0.711pm0.01$ using the pre-trained model for CN/AD. The interpretability analysis revealed significant grey matter modulations in cortical and subcortical brain areas well known for their association with AD. Moreover, impairments in sensory-motor and visual resting state network connectivity along the disease continuum, as well as mutations in SNPs defining biological processes linked to amyloid-beta and cholesterol formation clearance and regulation, were identified as contributors to the achieved performance. Overall, our integrative deep learning approach shows promise for AD detection and MCI prediction, while shading light on important biological insights.

Read more

6/21/2024

🤿

Multimodal hierarchical multi-task deep learning framework for jointly predicting and explaining Alzheimer disease progression

Sayantan Kumar, Sean Yu, Andrew Michelson, Thomas Kannampallil, Philip Payne

YC

0

Reddit

0

Objective: We aimed to develop and validate a novel multimodal framework HiMAL (Hierarchical, Multi-task Auxiliary Learning) framework, for predicting cognitive composite functions as auxiliary tasks that estimate the longitudinal risk of transition from Mild Cognitive Impairment (MCI) to Alzheimer Disease (AD). Methods: HiMAL utilized multimodal longitudinal visit data including imaging features, cognitive assessment scores, and clinical variables from MCI patients in the Alzheimer Disease Neuroimaging Initiative (ADNI) dataset, to predict at each visit if an MCI patient will progress to AD within the next 6 months. Performance of HiMAL was compared with state-of-the-art single-task and multi-task baselines using area under the receiver operator curve (AUROC) and precision recall curve (AUPRC) metrics. An ablation study was performed to assess the impact of each input modality on model performance. Additionally, longitudinal explanations regarding risk of disease progression were provided to interpret the predicted cognitive decline. Results: Out of 634 MCI patients (mean [IQR] age : 72.8 [67-78], 60% men), 209 (32%) progressed to AD. HiMAL showed better prediction performance compared to all single-modality singe-task baselines (AUROC = 0.923 [0.915-0.937]; AUPRC= 0.623 [0.605-0.644]; all p<0.05). Ablation analysis highlighted that imaging and cognition scores with maximum contribution towards prediction of disease progression. Discussion: Clinically informative model explanations anticipate cognitive decline 6 months in advance, aiding clinicians in future disease progression assessment. HiMAL relies on routinely collected EHR variables for proximal (6 months) prediction of AD onset, indicating its translational potential for point-of-care monitoring and managing of high-risk patients.

Read more

5/7/2024